Approval · Notice of Compliance 8950 · 2007
DUOVENT UDV: Notice of Compliance 8950
Issued July 30, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8950
- Date
- July 30, 2007
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revision to the action and clinical pharmacology section and other revisions to the product monograph
- Therapeutic class
- Bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DUOVENT UDV | Not yet assigned | — |
Medicinal ingredients
- IPRATROPIUM BROMIDE 0.125 MG per ML
- FENOTEROL HBR 0.3125 MG per ML